All posts by "Christopher Kew" →

Pay-for-delay pharmaceutical agreements have attracted scrutiny from regulators in the US and EU. With last year's repeal of the intellectual property exemption in the CCA, these agreements are at greater risk of Australian regulatory attention...

Read More →

On 4 June 2020, the Competition and Consumer Commission of Singapore issued an Infringement Decision against three companies for their involvement in anti-competitive agreements to rig tenders issued by Wildlife Reserves Singapore for the provision...

Read More →
Europe, Italy, cartel, leniency, immunity

Applying for leniency is not always E-C

February 2, 2016 | 0 Comments

The European Court of Justice has affirmed that leniency applications made to the EC are not binding on national competition authorities. Companies therefore need to submit separate leniency applications to the EC and the competition...

Read More →